Utilization of sequence variants as biomarkers to analyze population dynamics in cloned cell lines

Tzihsuan Jennifer Lin1,2, Kathryn M Beal1, Heather S DeGruttola

  • 1Cell Line Development, Bioprocess R&D, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc, Andover 01810, Massachusetts.